Protective signaling pathways of activated protein C in endothelial cells.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2007-10-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.107.157321PMID 18094393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Engineering a Disulfide Bond to Stabilize the Calcium-binding Loop of Activated Protein C Eliminates Its Anticoagulant but Not Its Protective Signaling Properties*

  2007cited by this paper
• Activated Protein C Decreases Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand by an EPCR- Independent Mechanism Involving Egr-1/Erk-1/2 Activation

  2007cited by this paper
• Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells

  2007cited by this paper
• The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.

  2007cited by this paper
• The ligand occupancy of endothelial protein C receptor switches the PAR-1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells

  2007cited by this paper
• Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C

  2007influential reference
• Sphingosine-1 Phosphate Prevents Monocyte/Endothelial Interactions in Type 1 Diabetic NOD Mice Through Activation of the S1P1 Receptor

  2006cited by this paper
• bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. The cytoprotective protein C pathway

  2006influential reference
• In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights.

  2005cited by this paper
• Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

  2005cited by this paper
• Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement

  2005cited by this paper
• Activated Protein C Induces Endothelial Cell Proliferation by Mitogen-Activated Protein Kinase Activation In Vitro and Angiogenesis In Vivo

  2004influential reference
• Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway

  2002cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• The protein C pathway

  2000cited by this paper
• Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.

  1999cited by this paper
• Endothelial Protein C Receptor

  1999cited by this paper
• Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate.

  1999cited by this paper

• Circulating Soluble EPCR Levels Are Reduced in Patients with Ischemic Peripheral Artery Disease and Associated with Markers of Endothelial and Vascular Function

  2023cites this paper
• Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19

  2021cites this paper
• Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19

  2021cites this paper
• The neuropeptide galanin promotes an anti-thrombotic phenotype on endocardial endothelial cells from heart failure patients.

  2017cites this paper
• Thrombomodulin improves rat survival after extensive hepatectomy.

  2015cites this paper
• Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the Brain

  2015cites this paper
• Discovery of novel interacting partners of PSMD9, a proteasomal chaperone: Role of an Atypical and versatile PDZ-domain motif interaction and identification of putative functional modules

  2014cites this paper
• Київський національний університет

  2013cites this paper
• Vitamin E: Metabolism and Requirements

  2013cites this paper
• Endothelial cell signalling of APC and thrombin : the involvement of protein kinase C

  2013cites this paper
• Protein C activation peptide inhibits the expression of ICAM-1, VCAM-1, and interleukin-8 induced by TNF-α in human dermal microvascular endothelial cells.

  2012cites this paper
• Upregulation of anticoagulant proteins, protein S and tissue factor pathway inhibitor, in the mouse myocardium with cardio-specific TNF-α overexpression.

  2012cites this paper
• The protein C pathway in cancer metastasis.

  2012cites this paper
• Phenylmethimazole inhibits production of proinflammatory mediators and is protective in an experimental model of endotoxic shock*

  2012cites this paper
• Protein C activation peptide inhibits the expression of ICAM-1, VCAM-1, and interleukin-8 induced by TNF-a in human dermal microvascular endothelial cells

  2012cites this paper
• rhAPC reduces the endothelial cell permeability via a decrease of contractile tensions induced by endothelial cells.

  2012cites this paper
• Vitamins C and E: beneficial effects from a mechanistic perspective.

  2011cites this paper
• High‐resolution X‐ray microtomography for three‐dimensional imaging of cardiac progenitor cell homing in infarcted rat hearts

  2011cites this paper
• The role of activated protein C in cancer progression.

  2010cites this paper
• mice anticoagulation mechanism and promotes coagulation in endotoxemic B pathway impairs protein C κ Activation of endothelial intrinsic

  2009cites this paper
• Activation of endothelial intrinsic NF-{kappa}B pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic mice.

  2009cites this paper
• Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

  2009cites this paper
• Nouveaux antithrombotiques veineux

  2006cites this paper